ADS-ADEA 2015*
Chair: Mark Cooper
This conference acknowledges the sponsorship of AstraZeneca and Eli Lilly
Update on Combination Basal Insulin Plus GLP-1 Receptor Agonist: how far have we gone ? (#63)
2:00 PM
Does hypoglycaemia oppose the macrovascular benefits of intensive glucose control? (#64)
2:00 PM